ID   LEUK_RAT                Reviewed;         378 AA.
AC   P13838;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   29-MAY-2024, entry version 133.
DE   RecName: Full=Leukosialin;
DE   AltName: Full=Leukocyte sialoglycoprotein;
DE   AltName: Full=Sialophorin;
DE   AltName: Full=W3/13 antigen;
DE   AltName: CD_antigen=CD43;
DE   Contains:
DE     RecName: Full=CD43 cytoplasmic tail;
DE              Short=CD43-ct;
DE              Short=CD43ct;
DE   Flags: Precursor; Fragment;
GN   Name=Spn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymocyte;
RX   PubMed=2965006; DOI=10.1002/j.1460-2075.1987.tb02747.x;
RA   Killeen N., Barclay A.N., Willis A.C., Williams A.F.;
RT   "The sequence of rat leukosialin (W3/13 antigen) reveals a molecule with O-
RT   linked glycosylation of one third of its extracellular amino acids.";
RL   EMBO J. 6:4029-4034(1987).
RN   [2]
RP   INTERACTION WITH EZR; MSN AND RDX, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   259-LYS--ARG-261.
RX   PubMed=9472040; DOI=10.1083/jcb.140.4.885;
RA   Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S.,
RA   Tsukita S.;
RT   "Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino
RT   acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and
RT   ICAM-2.";
RL   J. Cell Biol. 140:885-895(1998).
RN   [3]
RP   INTERACTION WITH SIGLEC1.
RX   PubMed=11238599; DOI=10.4049/jimmunol.166.6.3637;
RA   van den Berg T.K., Nath D., Ziltener H.J., Vestweber D., Fukuda M.,
RA   van Die I., Crocker P.R.;
RT   "CD43 functions as a T cell counterreceptor for the macrophage adhesion
RT   receptor sialoadhesin (Siglec-1).";
RL   J. Immunol. 166:3637-3640(2001).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-276; SER-326; SER-330;
RP   SER-354 AND THR-361, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Predominant cell surface sialoprotein of leukocytes which
CC       regulates multiple T-cell functions, including T-cell activation,
CC       proliferation, differentiation, trafficking and migration. Positively
CC       regulates T-cell trafficking to lymph-nodes via its association with
CC       ERM proteins (EZR, RDX and MSN). Negatively regulates Th2 cell
CC       differentiation and predisposes the differentiation of T-cells towards
CC       a Th1 lineage commitment. Promotes the expression of IFN-gamma by T-
CC       cells during T-cell receptor (TCR) activation of naive cells and
CC       induces the expression of IFN-gamma by CD4(+) T-cells and to a lesser
CC       extent by CD8(+) T-cells. Plays a role in preparing T-cells for
CC       cytokine sensing and differentiation into effector cells by inducing
CC       the expression of cytokine receptors IFNGR and IL4R, promoting IFNGR
CC       and IL4R signaling and by mediating the clustering of IFNGR with TCR.
CC       Acts as a major E-selectin ligand responsible for Th17 cell rolling on
CC       activated vasculature and recruitment during inflammation. Mediates
CC       Th17 cells, but not Th1 cells, adhesion to E-selectin. Acts as a T-cell
CC       counter-receptor for SIGLEC1. {ECO:0000250|UniProtKB:P15702,
CC       ECO:0000250|UniProtKB:P16150}.
CC   -!- FUNCTION: [CD43 cytoplasmic tail]: Protects cells from apoptotic
CC       signals, promoting cell survival. {ECO:0000250|UniProtKB:P15702}.
CC   -!- SUBUNIT: Interacts with SIGLEC1. {ECO:0000269|PubMed:11238599}.
CC   -!- SUBUNIT: [CD43 cytoplasmic tail]: Monomer (By similarity). Interacts
CC       with CTNNB1 (By similarity). Interacts with EZR, MSN and RDX (via FERM
CC       domain) (PubMed:9472040). {ECO:0000250|UniProtKB:P15702,
CC       ECO:0000250|UniProtKB:P16150, ECO:0000269|PubMed:9472040}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass type I
CC       membrane protein {ECO:0000255}. Cell projection, microvillus
CC       {ECO:0000269|PubMed:9472040}. Cell projection, uropodium
CC       {ECO:0000250|UniProtKB:P15702}. Note=Localizes to the uropodium and
CC       microvilli via its interaction with ERM proteins (EZR, RDX and MSN).
CC       {ECO:0000250|UniProtKB:P15702, ECO:0000269|PubMed:9472040}.
CC   -!- SUBCELLULAR LOCATION: [CD43 cytoplasmic tail]: Nucleus
CC       {ECO:0000250|UniProtKB:P15702}. Nucleus, PML body
CC       {ECO:0000250|UniProtKB:P15702}. Note=The sumoylated form localizes to
CC       the PML body. {ECO:0000250|UniProtKB:P15702}.
CC   -!- TISSUE SPECIFICITY: Cell surface of thymocytes, T-lymphocytes,
CC       neutrophils, plasma cells and myelomas.
CC   -!- PTM: Has a high content of sialic acid and O-linked carbohydrate
CC       structures.
CC   -!- PTM: Phosphorylation at Ser-330 is regulated by chemokines, requires
CC       its association with ERM proteins (EZR, RDX and MSN) and is essential
CC       for its function in the regulation of T-cell trafficking to lymph
CC       nodes. {ECO:0000250|UniProtKB:P15702}.
CC   -!- PTM: Cleavage by CTSG releases its extracellular domain and triggers
CC       its intramembrane proteolysis by gamma-secretase releasing the CD43
CC       cytoplasmic tail chain (CD43-ct) which translocates to the nucleus.
CC       {ECO:0000250|UniProtKB:P15702}.
CC   -!- PTM: [CD43 cytoplasmic tail]: Sumoylated.
CC       {ECO:0000250|UniProtKB:P15702}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00090; CAA68281.1; -; mRNA.
DR   PIR; S00842; S00842.
DR   AlphaFoldDB; P13838; -.
DR   SMR; P13838; -.
DR   STRING; 10116.ENSRNOP00000051894; -.
DR   GlyCosmos; P13838; 26 sites, No reported glycans.
DR   GlyGen; P13838; 26 sites.
DR   iPTMnet; P13838; -.
DR   PhosphoSitePlus; P13838; -.
DR   PaxDb; 10116-ENSRNOP00000051894; -.
DR   UCSC; RGD:3750; rat.
DR   AGR; RGD:3750; -.
DR   RGD; 3750; Spn.
DR   eggNOG; ENOG502SBHY; Eukaryota.
DR   InParanoid; P13838; -.
DR   PhylomeDB; P13838; -.
DR   TreeFam; TF337688; -.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-210991; Basigin interactions.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005604; C:basement membrane; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0032154; C:cleavage furrow; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0001931; C:uropod; ISS:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:RGD.
DR   GO; GO:0030544; F:Hsp70 protein binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0002544; P:chronic inflammatory response; IEP:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0050901; P:leukocyte tethering or rolling; ISS:UniProtKB.
DR   GO; GO:0042117; P:monocyte activation; IEP:RGD.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0050868; P:negative regulation of T cell activation; ISO:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0001808; P:negative regulation of type IV hypersensitivity; ISO:RGD.
DR   GO; GO:0045060; P:negative thymic T cell selection; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:2000406; P:positive regulation of T cell migration; ISS:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0050688; P:regulation of defense response to virus; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; IGI:ARUK-UCL.
DR   GO; GO:0050776; P:regulation of immune response; ISO:RGD.
DR   GO; GO:2000404; P:regulation of T cell migration; ISS:UniProtKB.
DR   GO; GO:0001562; P:response to protozoan; ISO:RGD.
DR   GO; GO:0031295; P:T cell costimulation; ISO:RGD.
DR   GO; GO:0042098; P:T cell proliferation; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0002296; P:T-helper 1 cell lineage commitment; ISS:UniProtKB.
DR   GO; GO:0071594; P:thymocyte aggregation; IMP:RGD.
DR   InterPro; IPR038829; Leukosialin.
DR   PANTHER; PTHR35265; LEUKOSIALIN; 1.
DR   PANTHER; PTHR35265:SF1; LEUKOSIALIN; 1.
PE   1: Evidence at protein level;
KW   Cell projection; Glycoprotein; Membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          <1..7
FT   CHAIN           8..378
FT                   /note="Leukosialin"
FT                   /id="PRO_0000021590"
FT   CHAIN           255..378
FT                   /note="CD43 cytoplasmic tail"
FT                   /evidence="ECO:0000250|UniProtKB:P15702"
FT                   /id="PRO_0000443408"
FT   TOPO_DOM        8..231
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        232..254
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        255..378
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          13..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          255..285
FT                   /note="Required for interaction with EZR, MSN and RDX and
FT                   for co-localization to microvilli"
FT                   /evidence="ECO:0000269|PubMed:9472040"
FT   REGION          265..378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           259..273
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P16150"
FT   COMPBIAS        293..326
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16150"
FT   MOD_RES         276
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16150"
FT   MOD_RES         316
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P16150"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15702"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         330
FT                   /note="Phosphoserine; by PKC/PRKCQ"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         361
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        13
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        15
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        20
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        23
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        25
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        27
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        28
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        29
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        33
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        34
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        36
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        37
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        40
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        108
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        113
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        118
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        120
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        124
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        125
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        126
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        174
FT                   /note="O-linked (GalNAc...) threonine"
FT   CARBOHYD        176
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        180
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        183
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        187
FT                   /note="O-linked (GalNAc...) serine"
FT   CARBOHYD        189
FT                   /note="O-linked (GalNAc...) threonine"
FT   MUTAGEN         259..261
FT                   /note="KRR->NGG: Loss of interaction with EZR, MSN and RDX
FT                   and co-localization to microvilli."
FT                   /evidence="ECO:0000269|PubMed:9472040"
FT   NON_TER         1
SQ   SEQUENCE   378 AA;  38426 MW;  231CC80E8A8A257C CRC64;
     WAQVVSQENL PNTMTMLPFT PNSESPSTSE ALSTYSSIAT VPVTEDPKES ISPWGQTTAP
     ASSIPLGTPE LSSFFFTSAG ASGNTPVPEL TTSQEVSTEA SLVLFPKSSG VASDPPVTIT
     NPATSSAVAS TSLETFKGTS APPVTVTSST MTSGPFVATT VSSETSGPPV TMATGSLGPS
     KETHGLSATI ATSSGESSSV AGGTPVFSTK ISTTSTPNPI TTVPPRPGSS GMLLVSMLIA
     LTVVLVLVAL LLLWRQRQKR RTGALTLSRG GKRNGTVDAW AGPARVPDEE ATTASGSGGN
     KSSGAPETDG SGQRPTLTTF FSRRKSRQGS VALEELKPGT GPNLKGEEEP LVGSEDEAVE
     TPTSDGPQAK DGAAPQSL
//
